The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum

Infection and Immunity

Volumn 71, Issue 5, 2003, Pages 2674-2683

  Lang, Thierry ^a   Courret, Nathalie ^a,b   Colle, Jean Hervé ^a   Milon, Geneviève ^a   Antoine, Jean Claude ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; PARASITE ANTIGEN; PROTEIN LACK; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMIS; DOSE RESPONSE; EAR INFECTION; FEMALE; INOCULATION; KINETICS; LEISHMANIA MAJOR; MOUSE; MOUSE STRAIN; NONHUMAN; PARASITE DEVELOPMENT; PARASITE VIRULENCE; PRIORITY JOURNAL; PROMASTIGOTE; SKIN DEFECT; SKIN INFECTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; INTERFERON TYPE II; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS;

EID: 0037406839     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.5.2674-2683.2003     Document Type: Article

References (48)

1. Antoine, J.-C., C. Jouanne, T. Lang, E. Prina, C. de Chastellier, and C. Fréhel. 1991. Localization of major histocompatibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis. Infect. Immun. 59:764-775.
2. Antoine, J.-C., C. Jouanne, and A. Ryter. 1989. Megasomes as the targets of leucine methyl ester in Leishmania amazonensis amastigotes. Parasitology 99:1-9.
3. Beil, W. J., G. Meinardus-Hager, D.-C. Neugebauer, and C. Sorg. 1992. Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J. Leukoc. Biol. 52:135-142.
4. Belkaid, Y., V. Bouckson, J.-H. Colle, P. Goossens, M. Lebastard, V. Leclercq, G. Marchal, C. Montixi, and G. Milon. 1994. Transient inducible events in different tissues: in situ studies in the context of the development and expression of the immune responses to intracellular pathogens. Immunobiology 191:413-423.
5. Belkaid, Y., B. Butcher, and D. L. Sacks. 1998. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur. J. Immunol. 28:1389-1400.
6. Belkaid, Y., S. Mendez, R. Lira, N. Kadambi, G. Milon, and D. Sacks. 2000. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 165:969-977.
7. Belosevic, M., D. S. Finbloom, P. H. Van Der Meide, M. V. Slayter, and C. A. Nacy. 1989. Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143:266-274.
8. Berens, R. L., and J. J. Marr. 1978. An easily prepared defined medium for cultivation of Leishmania donovani promastigotes. J. Parasitol. 64:160.
9. Bhattacharya, A., M. E. Dorf, and T. A. Springer. 1981. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J. Immunol. 127:2488-2495.
10. Carrera, L., R. T. Gazzinelli, R. Badolato, S. Hieny, W. Muller, R. Kuhn, and D. L. Sacks. 1996. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:515-526.
11. Colle, J.-H., P. B. Falanga, M. Singer, B. Hevin, and G. Milon. 1997. Quantitation of messenger RNA by competitive RT-PCR: a simplified read out assay. J. Immunol. Methods 210:175-184.
12. Courret, N., C. Fréhel, E. Prina, T. Lang, and J.-C. Antoine. 2001. Kinetics of the intracellular differentiation of Leishmania amazonensis and internalization of host MHC molecules by the intermediate parasite stages. Parasitology 122:263-279.
13. Courret, N., E. Prina, E. Mougneau, E. M. Saraiva, D. L. Sacks, N. Glaichenhaus, and J.-C. Antoine. 1999. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur. J. Immunol. 29:762- 773.
14. Dominguez, M., I. Moreno, M. Lopez-Trascasa, and A. Torano. 2002. Complement interaction with trypanosomatid promastigotes in normal human serum. J. Exp. Med. 195:451-459.
15. Etges, R., and I. Müller. 1998. Progressive disease or protective immunity to Leishmania major infection: the result of a network of stimulatory and inhibitory interactions. J. Mol. Med. 76:372-390.
16. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88:7011-7015.
17. Himmelrich, H., P. Launois, I. Maillard, T. Biedermann, F. Tacchini-Cottier, R. M. Locksley, M. Rocken, and J. A. Louis. 2000. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J. Immunol. 164:4819-4825.
18. + T cells which react to the Leishmania major LACK antigen rapidly secrete interleukin-4 and are detrimental to the host in resistant B10.D2 mice. Infect. Immun. 67:3641-3644.
19. Julia, V., M. Rassoulzadegan, and N. Glaichenhaus. 1996. Resistance to Leishmania major induced by tolerance to a single antigen. Science 274:421-423.
20. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97-104.
21. Kima, P. E., L. Soong, C. Chicharro, N. H. Ruddle, and D. McMahon-Pratt. 1996. Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells. Eur. J. Immunol. 26:3163-3169.
22. Kopf, M., F. Brombacher, G. Köhler, G. Kienzle, K.-H. Widmann, K. Lefrang, C. Humborg, B. Ledermann, and W. Solbach. 1996. IL-4-deficient BALB/c mice resist infection with Leishmania major. J. Exp. Med. 184:1127-1136.
23. Kruisbeek, A. M. 1994. In vitro assays for lymphocyte function, p. 3.1.5. In J. E. Colingan, A. M. Kruisbeek, D. H. Margullies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology, vol. 1. Wiley, New York, N.Y.
24. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6:541-549.
25. Launois, P., T. Ohteki, K. Swihart, H. R. MacDonald, and J. A. Louis. 1995, In susceptible mice, Leishmania major induces very rapid interleukin-4 production by CD4+ T cells which are NK1.1-. Eur. J. Immunol. 25:3298-3307.
26. Leclercq, V., M. Lebastard, Y. Belkaid, J. Louis, and G. Milon. 1996. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the lsh and MHC loci. J. Immunol. 157:4537-4545.
27. Liew, F. Y., S. Millott, C. Parkinson, R. M. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794-4797.
28. Lira, R., M. Doherty, G. Modi, and D. Sacks. 2000. Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major. Infect. Immun. 68:5176-5182.
29. Mosser, D. M., and A. Brittingham. 1997. Leishmania, macrophages and complement: a tale of subversion and exploitation. Parasitology 115:S9-S23.
30. Mougneau, E., F. Altare, A. E. Wakil, S. Zheng, T. Coppola, Z. E. Wang, R. Waldmann, R. M. Locksley, and N. Glaichenhaus. 1995. Expression cloning of a protective Leishmania antigen. Science 268:563-566.
31. Nicolas, L., S. Sidjanski, J.-H. Colle, and G. Milon. 2000. Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice. Infect. Immun. 68:6561-6566.
32. Noben-Trauth, N. 2000. Susceptibility to Leishmania major infection in the absence of IL-4. Immunol. Lett. 75:41-44.
33. Noben-Trauth, N., P. Kropf, and I. Müller. 1996. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 271:987-990.
34. Noben-Trauth, N., W. E. Paul, and D. L. Sacks. 1999. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J. Immunol. 162:6132-6140.
35. Oswald, I. P., R. T. Gazzinelli, A. Sher, and S. L. James. 1992. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J. Immunol. 148:3578-3582.
36. Prina, E., T. Lang, N. Glaichenhaus, and J.-C. Antoine. 1996. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages. J. Immunol. 156:4318-4327.
37. Radka, S. F., D. D. Kostyu, and D. B. Amos. 1982. A monoclonal antibody directed against the HLA-Bw6 epitope. J. Immunol. 128:2804-2806.
38. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
39. Sacks, D. L., S. Hieny, and A. Sher. 1985. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135:564-569.
40. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T-cell-dependent, interferon γ-independent mechanism. J. Exp. Med. 171:115-127.
41. Sartori, A., M. A. P. Oliveira, P. Scott, and G. Trinchieri. 1997. Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. J. Immunol. 159:2849-2857.
42. Seder, R. A., and W. E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12:635-673.
43. Stetson, D. B., M. Mohrs, V. Mallet-Designe, L. Teyton, and R. M. Locksley. 2002. Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo. Immunity 17:191-200.
44. Strijbosch, L. W., W. A. Buurman, R. J. Does, P. H. Zinken, and G. Groenewegen. 1987. Limiting dilution assays. Experimental design and statistical analysis. J. Immunol. Methods 97:133-140.
45. Tacchini-Cottier, F., C. Zweifel, Y. Belkaid, C. Mukankundiye, M. Vasei, P. Launois, G. Milon, and J. A. Louis. 2000. An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. J. Immunol. 165:2628-2636.
46. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614-1619.
47. Warburg, A., and Y. Schlein. 1986. The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major. Am. J. Trop. Med. Hyg. 35:926-930.
48. Wei, X.-Q., I. G. Charles, A. Smith, J. Ure, G.-J. Feng, F.-P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.